Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.

Häuser W, Petzke F, Fitzcharles MA.

Eur J Pain. 2017 Oct 15. doi: 10.1002/ejp.1118. [Epub ahead of print] Review.

PMID:
29034533
2.

Cannabinoids in Pain Management and Palliative Medicine.

Häuser W, Fitzcharles MA, Radbruch L, Petzke F.

Dtsch Arztebl Int. 2017 Sep 22;114(38):627-634. doi: 10.3238/arztebl.2017.0627.

3.

Unravelling Fibromyalgia-Steps Toward Individualized Management.

Häuser W, Perrot S, Clauw DJ, Fitzcharles MA.

J Pain. 2017 Sep 21. pii: S1526-5900(17)30700-9. doi: 10.1016/j.jpain.2017.08.009. [Epub ahead of print]

PMID:
28943233
4.

Pain management: Opioids for RA: a clinical dilemma.

Häuser W, Fitzcharles MA.

Nat Rev Rheumatol. 2017 Sep;13(9):521-522. doi: 10.1038/nrrheum.2017.123. Epub 2017 Aug 3. No abstract available.

PMID:
28769111
5.

Another Nasty Effect of Opioids: Attenuating the Benefits of Motivational Interviewing in Fibromyalgia?

Fitzcharles MA, Shir Y.

J Rheumatol. 2017 Apr;44(4):407-409. doi: 10.3899/jrheum.170076. No abstract available.

PMID:
28604346
6.

Impact of Moving From a Widespread to Multisite Pain Definition on Other Fibromyalgia Symptoms.

Dean LE, Arnold L, Crofford L, Bennett R, Goldenberg D, Fitzcharles MA, Paiva ES, Staud R, Clauw D, Sarzi-Puttini P, Jones GT, Ayorinde A, Flüß E, Beasley M, Macfarlane GJ.

Arthritis Care Res (Hoboken). 2017 Dec;69(12):1878-1886. doi: 10.1002/acr.23214. Epub 2017 Nov 2.

PMID:
28182834
7.

Management of fibromyalgia: practical guides from recent evidence-based guidelines.

Häuser W, Ablin J, Perrot S, Fitzcharles MA.

Pol Arch Intern Med. 2017 Jan 4;127(1):47-56. doi: 10.20452/pamw.3877. Epub 2017 Jan 4. Review.

8.

Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.

Pomares FB, Funck T, Feier NA, Roy S, Daigle-Martel A, Ceko M, Narayanan S, Araujo D, Thiel A, Stikov N, Fitzcharles MA, Schweinhardt P.

J Neurosci. 2017 Feb 1;37(5):1090-1101. doi: 10.1523/JNEUROSCI.2619-16.2016. Epub 2016 Dec 16.

9.

2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B.

Semin Arthritis Rheum. 2016 Dec;46(3):319-329. doi: 10.1016/j.semarthrit.2016.08.012. Epub 2016 Aug 30.

PMID:
27916278
10.

Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis.

Ste-Marie PA, Shir Y, Rampakakis E, Sampalis JS, Karellis A, Cohen M, Starr M, Ware MA, Fitzcharles MA.

Pain. 2016 Dec;157(12):2792-2797.

PMID:
27842047
11.

Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases.

Fitzcharles MA, Häuser W.

Curr Rheumatol Rep. 2016 Dec;18(12):76. doi: 10.1007/s11926-016-0625-5. Review.

PMID:
27832442
12.

Dr. Fitzcharles, et al, reply.

Fitzcharles MA, Ste-Marie PA, Rampakakis E, Sampalis JS, Shir Y.

J Rheumatol. 2016 Nov;43(11):2077. No abstract available.

PMID:
27803347
13.

Cannabinoids for fibromyalgia.

Walitt B, Klose P, Fitzcharles MA, Phillips T, Häuser W.

Cochrane Database Syst Rev. 2016 Jul 18;7:CD011694. doi: 10.1002/14651858.CD011694.pub2. Review.

PMID:
27428009
14.

Treat-to-Target Strategy for Fibromyalgia: Opening the Dialogue.

Häuser W, Clauw DJ, Fitzcharles MA.

Arthritis Care Res (Hoboken). 2017 Apr;69(4):462-466. doi: 10.1002/acr.22970. Epub 2017 Feb 28. Review. No abstract available.

PMID:
27390268
15.

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders.

Ablin JN, Elkayam O, Fitzcharles MA.

Rambam Maimonides Med J. 2016 Apr 19;7(2). doi: 10.5041/RMMJ.10239.

16.

Pain Management for the Young Adult Rheumatology Patient in an Era of Medicinal Marijuana Legalization.

Fitzcharles MA, Hazel EM, Taylor G, Tucker LB.

J Rheumatol. 2016 Apr;43(4):686-8. doi: 10.3899/jrheum.150103. No abstract available.

PMID:
27037241
17.

Disability in Fibromyalgia Associates with Symptom Severity and Occupation Characteristics.

Fitzcharles MA, Ste-Marie PA, Rampakakis E, Sampalis JS, Shir Y.

J Rheumatol. 2016 May;43(5):931-6. doi: 10.3899/jrheum.151041. Epub 2016 Mar 15.

PMID:
26980580
19.

Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA.

Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.

PMID:
26767992
20.

Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials.

Fitzcharles MA, Ste-Marie PA, Häuser W, Clauw DJ, Jamal S, Karsh J, Landry T, Leclercq S, Mcdougall JJ, Shir Y, Shojania K, Walsh Z.

Arthritis Care Res (Hoboken). 2016 May;68(5):681-8. doi: 10.1002/acr.22727. Review.

Supplemental Content

Loading ...
Support Center